论文部分内容阅读
目的：观察初发2型糖尿病采用二甲双胍缓释片联合津力达进行治疗的有效性。方法：抽取2014年3月1日～2014年8月1日到我院接受治疗的60例初发2型糖尿病患者作为研究对象，分成观察组与对照组，对照组采用二甲双胍缓释片进行治疗，观察组在对照组治疗基础上采用津力达治疗，对比两组患者治疗效果。结果：观察组用药后空腹血糖、餐后2h血糖、糖化血红蛋白分别为（5.3±2.1）、（6.2±2.9）、（5.3±2.1），与对照组相比具有明显差异（P＜0.05）；观察组与对照组治疗有效性分别为93.33%、73.33%，观察组治疗效果较高（P＜0.05）；观察组与对照组不良反应发生率分别为13.33%、30.00%，观察组不良反应较低（P＜0.05）。结论：二甲双胍缓释片用于初发2型糖尿病临床治疗中，获得较为明显降糖效果的效果，可控制患者的血糖，，而津力达可促进患者便秘、口干等症状得到明显改善，两者联合使用，可提高患者生活质量，明显改善患者治疗预后，值得临床推广应用。“,”Objective To observe the incipient type 2 diabetes treated with metformin zyban joint tianjin eed is effective.Methods From March 1, 2014-2014, August 1 to our hospital for treatment of 60 patients with incipient type 2 diabetes as the research object, is divided into observation group and control group, control group treated with metformin zyban, observation group in the control group, treatment based on using tianjin eed, compared two groups of patients with therapeutic effect.Results The observation group after fasting blood glucose, 2 h postprandial blood glucose, glycosylated hemoglobin, respectively (5.3±2.1), (6.2±2.9), (5.3±2.1), compared with the control group with significant difference (P < 0.05); Observation group and control group in treatment effectiveness is respectively 93.33%, 73.33%, treatment group effect is higher (P < 0.05); Observation group and control group in incidence of adverse reactions were 13.33%, 30.00%, observation group low adverse reaction (P < 0.05).Conclusion Metformin zyban for incipient type 2 diabetes mellitus in the clinical treatment, achieve the result of more obvious hypoglycemic effect, can control the blood sugar, patients, and tianjin eed can promote dramatically improve patients with symptoms such as constipation, dry mouth, a combination of both, can improve the patients quality of life, improving the prognosis of patients obviously, is worth clinical application.